Full Press Release Details
IDEAYA Appoints Garret Hampton Ph D to the Board of Directors an Industry Leader in Precision Medicine Oncology and Diagnostics.
IDYA
IDEAYA Appoints Garret Hampton Ph D to the Board of Directors an Industry Leader in Precision Medicine Oncology and Diagnostics
Key Takeaway: IDEAYA Appoints Garret Hampton Ph D to the Board of Directors an Industry Leader in Precision Medicine Oncology and Diagnostics
BiopharmaWatch Analysis
From our catalyst data and publicly available data · not financial adviceBest trade, last catalyst
+47%
120-day peak, hindsight
Typical move
5.2%
average across 6 past catalysts
Cash runway
~42 mo
Minimal dilution risk
Lead asset
IDE892
Phase 1 · NSCLC Adenocarcinoma